The expression levels of the cannabinoid receptors, particularly the CB2 receptor, have been demonstrated to be altered in Parkinson’s disease patients, so we wished to determine if there were alterations induced in the gene expression of these receptors in the rat brain by this viral-mediated α-synuclein overexpression. The gene discussed is SNCA; the disease is Parkinson disease.